Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session.
Agenus disclosed a 1-for-20 reverse stock split of common stock.
Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday.
The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500 also rose, gaining, 0.24% to 5,216.95.
Key Takeaways:
Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion
The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months
By Doug Young
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Monday.
Following the market opening Monday, the Dow traded up 0.18% to 38,974.17 while the NASDAQ rose 0.17% to 16,276.01. The S&P 500 also rose, gaining, 0.10% to 5,209.69.
On Monday, Hyundai Motor Company (OTC: HYMTF) and Kia Corporation signed a memorandum of understanding with Exide Energy Solutions Ltd with the aim of localizing EV battery production in India, joining the efforts of Tesla Inc (NASDAQ: TSLA